tradingkey.logo
tradingkey.logo
Pesquisar

Nuwellis Inc

NUWE
Adicionar à lista de desejos
3.150USD
+0.010+0.32%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
5.31MValor de mercado
2.31P/L TTM

Mais detalhes de Nuwellis Inc Empresa

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Informações de Nuwellis Inc

Código da empresaNUWE
Nome da EmpresaNuwellis Inc
Data de listagemFeb 16, 2012
CEOErb (John L)
Número de funcionários38
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 16
Endereço12988 Valley View Rd
CidadeEDEN PRAIRIE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55344
Telefone19523454200
Sitehttps://www.nuwellis.com/
Código da empresaNUWE
Data de listagemFeb 16, 2012
CEOErb (John L)

Executivos da empresa Nuwellis Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Nuwellis Inc?

Os cinco principais acionistas de Nuwellis Inc são: Mr. Gregory D. (Greg) Waller

Quantas instituições possuem ações da Nuwellis Inc (NUWE)?

Em 2026Q1, 20 instituições possuíam ações da Nuwellis Inc, com valor de mercado aproximado de 135.71K, representando 6.78% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 58953.00.